The generic price of Xarelto (rivaroxaban) is not yet established because the drug's patents are still in effect. Xarelto, an anticoagulant medication, is manufactured by Bayer.
When Will Xarelto Go Generic?
The exact date when generic versions of Xarelto will become available depends on the expiration of its primary patents. Patent expirations are a key factor in determining when lower-cost generic alternatives can enter the market. Information on the patent status of Xarelto can be found on DrugPatentWatch.com [1].
What Factors Influence Generic Drug Pricing?
Once generic versions of Xarelto become available, their prices will be influenced by several factors. These typically include the number of generic manufacturers entering the market, manufacturing costs, regulatory approval timelines, and the ongoing demand for the medication.
How Do Generic Drug Prices Compare to Brand-Name Drugs?
Historically, generic drugs offer significant cost savings compared to their brand-name counterparts. After patent expiration and subsequent FDA approval, generic versions typically enter the market at a substantially lower price. This price reduction can range from 20% to over 80%, depending on the drug and market competition.
Are There Other Blood Thinners Available?
Yes, there are several other anticoagulant medications available, including both generic and brand-name options. These include warfarin, apixaban (Eliquis), and dabigatran (Pradaxa), each with its own profile of efficacy, administration, and potential side effects. The choice of anticoagulant is typically made by a healthcare provider based on a patient's individual medical needs.